Indian scientists have developed a new smart cancer drug candidate designed to become active primarily inside cancer cells, offering a potentially more targeted approach to cancer treatment and reducing the risk of damage to healthy cells. 

The research has been led by Dr Asis Bala of the Institute of Advanced Study in Science and Technology (IASST), an autonomous institute under the Department of Science and Technology, Government of India, in collaboration with Dr K.P. Bhabak of the Indian Institute of Technology Guwahati.